Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
37.06 USD | -3.29% | +2.52% | -9.08% |
05-21 | JPMorgan Starts Structure Therapeutics With Overweight Rating | MT |
05-09 | Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.08% | 1.73B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- BMO Capital Adjusts Structure Therapeutics Price Target to $83 From $40, Maintains Outperform Rating